G. Motykie, L. Zebala, J. Caprini, C. Lee, J. Arcelus et al., A guide to venous Thromboembolism risk factor assessment, Journal of Thrombosis and Thrombolysis, vol.9, issue.3, pp.253-262, 2000.
DOI : 10.1023/A:1018770712660

J. Edelsberg, D. Ollendorf, and G. Oster, Venous thromboembolism following major orthopedic surgery: review of epidemiology and economics, AmJ Health Syst Pharm, vol.58, issue.2, pp.4-13, 2001.

F. Rosendaal, Risk factors for venous thrombotic disease, Thromb Haemost, vol.82, pp.610-619, 1999.

I. Martinelli, Risk factors in venous thromboembolism, Thromb Haemost, vol.86, pp.395-403, 2001.

G. Gensini, D. Prisco, M. Falciani, M. Comeglio, and A. Colella, Identification of Candidates for Prevention of Venous Thromboembolism, Seminars in Thrombosis and Hemostasis, vol.23, issue.01, pp.55-56, 1997.
DOI : 10.1055/s-2007-996071

V. Eschwege and A. Robert, Strikes in French public transport and resistance to activated protein C, The Lancet, vol.347, issue.8995, p.206, 1996.
DOI : 10.1016/S0140-6736(96)90393-1

I. Martinelli, Risk factors in venous thromboembolism, Thromb Haemost, vol.86, pp.395-403, 2001.

. Mismetti, Pr??vention de la maladie thromboembolique en orthop??die et traumatologie, Annales Fran??aises d'Anesth??sie et de R??animation, vol.24, issue.8, pp.871-889, 2005.
DOI : 10.1016/j.annfar.2005.06.007

G. Turpie, Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial, The American Journal of Cardiology, vol.86, issue.12, pp.48-52, 2000.
DOI : 10.1016/S0002-9149(00)01481-8

T. Paul, . Vaitkus, . Leizorovicz, and . Goldhaber, Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study), Vascular Medicine, vol.7, issue.4, pp.269-273, 2002.

T. Alexander and . Cohen, Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial, BMJ, vol.332, issue.7537 11, pp.325-354, 2006.

-. Bosson, J. Pouchain, and . Bergmann, A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices, Journal of Internal Medicine, vol.91, issue.24, pp.168-176, 2006.
DOI : 10.1007/s11239-004-0208-6

URL : https://hal.archives-ouvertes.fr/hal-00281342

P. Kujath, U. Spannagel, and W. Habscheid, Incidence and Prophylaxis of Deep Venous Thrombosis in Outpatients with Injury of the Lower Limb, Pathophysiology of Haemostasis and Thrombosis, vol.23, issue.1, pp.20-26, 1993.
DOI : 10.1159/000216905

H. Kock, K. Schmit-neuerburg, J. Hanke, G. Rudofsky, and H. Hirche, Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg, The Lancet, vol.346, issue.8973, pp.459-61, 1995.
DOI : 10.1016/S0140-6736(95)91320-3

P. Jorgensen, T. Warming, K. Hansen, and C. Palved, Low molecular weight heparin (Innohep) as thromboprophylaxis in outpatients with a plaster cast, Thrombosis Research, vol.105, issue.6, pp.477-80, 2002.
DOI : 10.1016/S0049-3848(02)00059-2

M. Lassen, L. Borris, and R. Nakov, Use of the Low-Molecular-Weight Heparin Reviparin to Prevent Deep-Vein Thrombosis after Leg Injury Requiring Immobilization, New England Journal of Medicine, vol.347, issue.10, p.726, 2002.
DOI : 10.1056/NEJMoa011327

B. Riou, C. Rothmann, and N. Lecoules, Incidence and risk factors for venous thromboembolism in patients with nonsurgical isolated lower limb injuries, The American Journal of Emergency Medicine, vol.25, issue.5, pp.502-510, 2007.
DOI : 10.1016/j.ajem.2006.09.012

URL : https://hal.archives-ouvertes.fr/hal-00281333

B. Ettema, Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials, Journal of Thrombosis and Haemostasis, vol.9, issue.1, pp.1093-1098, 2008.
DOI : 10.1111/j.1538-7836.2007.02570.x

M. Testroote, W. Stigter, D. De-visser, and H. Janzing, Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization " Department of Surgery and Orthopaedic Surgery, Viecuri Medical Centre of Northern Limburg BL. marktestroote@yahoo.com : Cochrane Database Syst Rev Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery, CD006681. 22, pp.5912-678, 2008.

F. Etude, NCT00843492?order=1 droit d'opposition à la transmission de vos données couvertes par le secret professionnel susceptibles d'être utilisées dans le cadre de cette recherche et d'être traitées en contactant le centre de coordination

. Un-comité-d-'ethique, Comité d'Ethique des Centres d'Investigation Clinique de l'Inter région Rhône-Alpes-Auvergne) a donné un avis favorable à la réalisation de cette recherche

A. Decisionnel and S. Prescrite, Amélioration Pas d'amélioration Traitement préventif Pas de traitement Mineurs : Obésité Insuffisance respiratoire Insuffisance cardiaque Pilule Insuffisance veineuse Déshydratation Périmètre de marche > 10 m Nuls : Tabac Contre indications HBPM : Clairance Créatinine<30 Grossesse 1 er trimestre Allergie vraie Variables recueillies à J0 Accès par mot de passe puis : N° centre??????? N° patient :?????? Sexe

S. Oui, Type d'immobilisation A B Prophylaxie par HBPM : Oui Non Si Oui : menu déroulant Tinzaparine sodique (Innohep®) 4500UiAntiXa/0,45ml /J Enoxaparine (lovenox®) 40mg, J Fondaparinux (Arixtra®), vol.2

D. Du-pas, Normal Anormal Pas d'appui